Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for NEXIUM 24HR
- Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects
- Vonoprazan for Helicobacter Pylori Eradication in Adolescents
- Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology
- Eradication of Helicobacter Pylori With Bismuth Agent Quadruple and Traditional Chinese Medicine
- PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers
- Proton Pump Inhibitors Effects on Dyspepsia During Ramadan Fasting
- Study to Assess the Efficacy and Safety of NEXIUM for Maintenance of Healing of Erosive Esophagitis
- Bioequivalence Study of Esomeprazole 20 Milligram (mg) Delayed-Release Capsules in Healthy Adult Participants
- Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy
- Bioequivalence Study of Esomeprazole From Stomopral 40 mg Capsules Contain Enteric Coated Pellets (Future Pharmaceuticals Industries, Egypt) and Nexium 40 mg Delayed Release Capsules (AstraZeneca Sweden, Product of France)
- Study to Evaluate Effects of Food or Proton Pump Inhibitor on the Pharmacokinetics of Itraconazole in Healthy Volunteers
- The Effect of PPI in Preventing Gastroesophageal Reflux Disease of Seafarers
- Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
- Study to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy Volunteers
- The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication
- A Study to Assess the Levels in Blood Plasma of BMS-986278 in Healthy Participants Following Administration of Tablets, With or Without Food, and in the Presence of an Antacid (Esomeprazole)
- Lactoferrin in Helicobacter Pylori Eradication Either With Standard Triple Therapy or Sequential Therapy
- Clinical Trial to Assess the PK/PD of YYD601 20mg After Oral Administration if Healthy Adult Subjects (Phase1)
- Clinical Trial to Assess the Efficacy and Safety of YYD601 in the Treatment of Esophageal Reflux Disease (ERD)
- A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis
- A Study of Esomeprazole in Children With Autism
- A Trial to Evaluate the Effect of the Proton Pump Inhibitor Esomeprazole on the Single-dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult Participants
- Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Male Participants
- An Open-Label Pilot Study of Esomeprazole in Children With Autism
- Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy
- PK/PD Clinical Trial of YYD601 in Healthy Adult Male
- Safety Trial of Herbal Melanin in Gastritis Patients
- Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy
- Pharmacokinetics and Safety Studies of Esomeprazole Use in Schizophrenia Patients
- Esomeprazole in Treatment of Early Onset Preeclampsia (ESOPE Trial)
- A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects
- Sequential Versus Quadruple Therapy in the Second-line Treatment
- Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)
- Effect of Vitamin D on Drug Resistant Helicobacter Pylori (HP) Eradication Study
- A Study to Evaluate the Bioequivalence of Single Oral Dose of Esomeprazole Capsule and Tablet Formulation in Healthy Participants
- Cooperative Group for Clinical Research in G-POEM (POP), Jiangsu, China
- Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored Therapy
- Implementation of PPI Medication PGX Testing
- Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection
- Pilot Study To Investigate The Association Between Acid Control And Heartburn Symptoms After Proton Pump Inhibitor Treatment
- Bioequivalence Study of Torrent Pharmaceutical Ltd's Esomeprazole Magnesium Delayed Release Capsules
- BE of Torrent's Esomeprazole Mg DR Capsules
- Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD
- Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Esomeprazole Magnesium DR Capsules Under Fasting Conditions
- Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication
- High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection
- Bioequivalence of Two Formulations of Esomeprazole
- The Primary Symptoms of GERD(Gastroesophageal Reflux Disease) in Chinese Outpatients in Gastroenterology Department
- Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis
- Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients
- A Pharmacokinetic Study to Evaluate the Bioequivalence of a Test Formulation Compared to an Equivalent Dose of a Reference Drug Product
- Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy
- Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances
- Stress Ulcer Prophylaxis of Intravenous Esomeprazole in Chinese Seriously Ill Patients
- Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional Dyspepsia
- Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study
- Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis
- Effect of Proton Pump Inhibitors on CF Pulmonary Exacerbations
- The PK and PD Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy Subjects
- PPI for Prevention of Post-sphincterotomy Bleeding
- YH4808 Postprandial PK/PD Study in Healthy Subjects
- High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer
- Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)
- Twenty-Four Hour Combined Multi-Channel Impedance and pH Ambulatory Monitoring: Impedance Reflux Episodes of Patients On and Off Proton Pump Inhibitor Therapy
- The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers
- Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis
- Safety, Tolerability, PK, PD of Escalating Single and Multiple Oral Doses of CJ-12420 in Healthy Male Subjects
- Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBIC
- BRAVO Study for Functional Dyspepsia
- A Double Blind Study Comparing Two Doses of IV Esomeprazole After Successful Endoscopic Therapy
- Effect of Dexlansoprazole on Bone Homeostasis
- VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK
- Study to Evaluate the Interaction Between Aspirin and Nexium
- A Study to Evaluate the Effect on 24-hour, Intragastric pH of RAB ER 50-mg Capsules Compared With Esomeprazole (Nexium) 40 mg Capsules and Rabeprazole (Aciphex) 20-mg Tablets
- Effect of IV and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic Therapy
- Viokase 16, Viokase16 Plus Nexium and Nexium Alone
- Plasm Gastrin Concentrations in Response to Nexium Administration in Healthy Volunteers
- Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.
- Oral vs Intravenous and Proton Pump Inhibitor (PPI）for Peptic Ulcer Bleeding (PUB)
- Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD
- Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving Performance
- The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection
- Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately
- Gastric Functions & Proton Pump Inhibitor( PPI) Study
- A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.
- Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding
- Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux
- Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment
- 13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors)
- Study Using Esomeprazole as a Diagnostic Test for GERD in Patients With NCCP
- A Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels
- Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial
- A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)
- The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
- The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 Diabetes
- Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination
- Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)
- Drug Interaction Study Between AZD3355 and Nexium
- Drug-Drug Interaction Study of Esomeprazole (D961H) Capsule and Loxoprofen Tablet After Repeated Oral Administration in Japanese Males
- Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US
- Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection
- Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed
- A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or S
- Barrett's Esophagus - 315 - 3 Way Cross Over
- Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)
- Barrett's Esophagus - 315 - 3 Way Cross-Over
- Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously
- Reflux Esophagitis Phase III Study (Maintenance Treatment)
- Reflux Esophagitis Phase III Study (Initial Treatment)
- A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued
- A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US Only
- Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care Unit
- Ulcer Prevention II
- An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflu
- Prevention of Gastric Ulcers
- Adult Asthmatics and Acid Reflux
- Chronic Posterior Laryngitis With Suspected Laryngopharyngeal Reflux
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux
- A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroe
- Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv
- Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)
- A Randomized, Open-Label, Comparative 3-Way Treatment Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40mg, Lansoprazole 30mg, and Pantoprazole 40mg at Steady State in NSAID-Using Patients
- Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected Patients
- Effect of Acid Suppression With Esomeprazole on Vocal Cord Granulomas
- In Vivo Quantification of Dental Demineralisation Using OCT With and Without Esomeprazole
- Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID
- A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)
- Phase 1 Pharmacokinetics of Intravenous Nexium in Children
- Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients
- Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression
- Total Antioxidant Effects of Esomeprazole in Dyspeptic Patients Receiving Non-steroidal Anti-inflammatory Drugs
- An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium
- A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine.
- Study of Proton Pump Inhibitors (PPI) to Prevent Strictures After Gastric Bypass Surgery
- A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia
- PLUTO: Pediatric Lipid-redUction Trial of rOsuvastatin
- A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer
- Nexium RESPONSE Trial
- PPI Test in GP Patients
- Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma
- Nexium 40mg Once Daily vs Prevacid 30mg Twice a Day for Control of Severe GERD
- The Utility of Nexium in Chronic Cough and Reflux Disease
- Nexium Dyspepsia/AST
- A Study to Prevent Rebleeding After Initial Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer
- ASTERIX: Low Dose ASA and Nexium
- Esomeprazole (NEXIUM) vs. Surgery
- Nexium Dyspepsia/AST
- Chest Pain Pilot Study
- An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)
- Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus
- Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects
- The Effects of Nexium on the Side Effects Associated With a Colonoscopy Prep
- Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients
- Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy
- The Effect of Nexium on Transmucosal Esophageal Leak
- Nexium Study To Suppress Nausea During Chemotherapy
- NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis
- Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg po
- On Demand Treatment of Reflux Disease
- Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy
- Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis
- Study of Acid Reflux in Asthma
Clinical trials list
click for details